Флутиформ

Флутиформ combines fluticasone propionate and formoterol fumarate for inhalation use, providing anti-inflammatory and bronchodilator effects. This combination inhaler supports airway management in adults and adolescents. Suitable for asthma and COPD maintenance therapy. Prescription required.

Flutiform is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and older. It combines a corticosteroid (fluticasone) to reduce inflammation and a long-acting beta-agonist (formoterol) to relax airway muscles. Regular use helps maintain open airways and reduce flare-ups.

This inhaler works to reduce swelling in the airways and keep them open, making breathing easier over time. Users may notice improved airflow and fewer asthma or COPD symptoms with consistent use. Effects build gradually and are most effective when used as prescribed.

Store in a dry place away from direct sunlight and extreme temperatures. Keep out of reach of children. Do not puncture or burn the inhaler. Rinse your mouth after use to reduce the risk of oral thrush. Always follow the handling instructions provided with the device.

This medication may interact with other inhaled corticosteroids, beta-blockers, or medicines that affect heart rhythm. Avoid using alcohol while taking this inhaler unless advised otherwise by a healthcare professional. CYP3A4 inhibitors, such as certain antifungals or antivirals, may increase the effects of fluticasone.